SCHEMBL4364295

SCHEMBL4364295

CC(=O)N1CN(CC(=O)O)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 5/20 0.55
▸ AMPD2 Q01433 1/20 0.46
▸ NOTUM Q6P988 8/20 0.44
▸ HSD17B3 P37058 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3038425 0.83 ADORA3 (0.43) BRD4POLBCYP2D6CYP2C19CYP2C9
SCHEMBL17792927 0.79 POLB (0.42) BRD4POLBCYP2D6CYP2C19CYP2C9
SCHEMBL13444609 0.73 ALDH1A1 (0.54) BRD4POLBCYP2D6CYP2C19CYP2C9
Bicarbonate SCHEMBL26677806 0.67 BRD4 (0.44) BRD4POLBKMT2A
SCHEMBL9545365 0.67 NOTUM (0.51) BRD4AMPD2NOTUMHSD17B3POLB
SCHEMBL18711338 0.67 BRD4 (0.62) BRD4AMPD2NOTUMHSD17B3POLB
SCHEMBL19051053 0.67 BDKRB2 (0.41) BRD4NOTUMPOLBKMT2A
Acetic Acid SCHEMBL29250276 0.66 GAA (0.48) BRD4NOTUMHSD17B3POLBKMT2A
Hydrochloric Acid SCHEMBL3854539 0.66 MAPT (0.48) KMT2ACYP3A4
SCHEMBL8793695 0.66 KMT2A (0.42) HSD17B3POLBCYP2D6CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051967-A1 BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATMENT OF VALLINOID RECEPTOR TRPV1 RELATED DISORDERS AstraZeneca AB (SE) 2009-04-29 — — EP disclosed
WO-2008018827-A1 BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATMENT OF VALLINOID RECEPTOR TRPV1 RELATED DISORDERS ASTRAZENECA AB (SE) 2008-02-14 — — WO disclosed
Send feedback